Cargando…
A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice
OBJECTIVES: Peripheral neuropathy is a relevant dose‐limiting adverse event that can affect up to 90% of oncologic patients with colorectal cancer receiving oxaliplatin treatment. The severity of neurotoxicity often leads to dose reduction or even premature cessation of chemotherapy. Unfortunately,...
Autores principales: | Calls, Aina, Torres‐Espin, Abel, Tormo, Marc, Martínez‐Escardó, Laura, Bonet, Núria, Casals, Ferran, Navarro, Xavier, Yuste, Víctor J., Udina, Esther, Bruna, Jordi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735376/ https://www.ncbi.nlm.nih.gov/pubmed/36369764 http://dx.doi.org/10.1002/acn3.51691 |
Ejemplares similares
-
Senescence in neurons: an open issue
por: Bruna, Jordi, et al.
Publicado: (2021) -
Dose Effects of Oxaliplatin on Persistent and Transient Na(+) Conductances and the Development of Neurotoxicity
por: Park, Susanna B., et al.
Publicado: (2011) -
Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN)
por: Argyriou, Andreas A.
Publicado: (2015) -
Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2021) -
Oxaliplatin neurotoxicity – no general ion channel surface-charge effect
por: Broomand, Amir, et al.
Publicado: (2009)